Skip to main content

Table 3 Availability of biological drugsa

From: Delivery of paediatric rheumatology care: a survey of current clinical practice in Southeast Asia and Asia-Pacific regions

Country (n)b Australia (13) China,
Hong Kong (2)
China, Taiwan (4) India (28) Indonesia (4) Laos (1) Malaysia (198) Myanmar (31) Nepal (1) New Zealand (2) Pakistan (2) The Philippines (2) Singapore (3) Thailand (44) Vietnam (2)
Medication
Adalimumab
Etanercept
Golimumab
Infliximab
Anakinra
Canakinumab
Tocilizumab
Belimumab
Rituximab
Abatacept
Secukinumab
Tofacitinib
Ustekinumab
  1. aThe data obtained during the study period
  2. bThe number of responses per country, 3 missed